Generated by GPT-5-mini| McCann Health | |
|---|---|
| Name | McCann Health |
| Type | Subsidiary |
| Industry | Advertising |
| Founded | 1998 |
| Headquarters | New York City |
| Area served | Worldwide |
| Key people | (see Corporate Structure and Leadership) |
| Parent | Interpublic Group |
McCann Health McCann Health is a global healthcare communications network operating within the advertising and marketing sector, engaging with pharmaceutical, biotechnology, medical device, and public health clients. The network works across advertising campaigns, medical education, digital strategy, and brand development for major healthcare companies and institutions, collaborating with creative agencies, regulatory bodies, and professional societies. It participates in industry events and alliances that include multinational corporations, academic centers, and nonprofit organizations.
The network traces roots through the lineage of McCann Erickson and acquisitions involving Interpublic Group of Companies and regional healthcare agencies in the late 20th and early 21st centuries. Key milestones include expansion into Europe, Asia, and Latin America driven by mergers with firms originally based in London, New York City, and Sydney, and strategic hires from agencies such as Ogilvy and FCB that brought expertise in pharmaceutical advertising. The group evolved alongside regulatory shifts influenced by agencies like the U.S. Food and Drug Administration, the European Medicines Agency, and public health initiatives from organizations such as the World Health Organization, adapting services to direct-to-consumer and professional-targeted communications. Its growth paralleled the consolidation trends led by holding companies including WPP plc, Omnicom Group, and Publicis Groupe, and participation in campaigns during global health events shaped relationships with academic centers like Johns Hopkins University and Harvard Medical School.
McCann Health operates as a specialized unit within Interpublic Group of Companies and coordinates with other Interpublic subsidiaries, including MullenLowe Group and FCB Health. Executive leadership has included industry veterans who previously held roles at agencies such as Saatchi & Saatchi, JWT, and Leo Burnett. Regional presidents and global chiefs frequently have backgrounds at multinationals like Pfizer, GlaxoSmithKline, and Roche or from advisory roles with institutions such as the Centers for Disease Control and Prevention and the National Institutes of Health. Board-level oversight involves representatives tied to investment arms like IPG Mediabrands and corporate governance informed by shareholders including institutional investors and family offices familiar with media holdings.
The network offers integrated services: brand strategy, creative advertising, medical education, digital health, multichannel marketing, real-world evidence communication, and patient engagement programs. It serves clients across therapeutic areas such as oncology, cardiology, immunology, and neurology, collaborating with scientific societies like the American Society of Clinical Oncology, the European Society of Cardiology, and registries tied to hospitals like Mayo Clinic and Cleveland Clinic. Services often require compliance with regulatory frameworks from agencies including the U.S. Food and Drug Administration and the European Medicines Agency, and adherence to codes from trade bodies such as the International Federation of Pharmaceutical Manufacturers & Associations and national advertising standards authorities. Technical specializations include health economics and outcomes research communications, working with consultancies like IQVIA and McKinsey & Company-affiliated healthcare practices.
The agency has executed campaigns for multinational pharmaceutical companies such as Pfizer, Novartis, Sanofi, AstraZeneca, and Johnson & Johnson, and for medical device firms like Medtronic and Boston Scientific. Campaigns have intersected with public health initiatives by groups including the World Health Organization and national ministries of health in countries including United States, United Kingdom, India, and Brazil. Notable programs partnered with patient advocacy groups such as American Cancer Society and Alzheimer's Association and with payers like UnitedHealth Group and Aetna. Collaborations with research funders and academic trials—often registered with platforms like ClinicalTrials.gov—involved communicating trial recruitment and outcomes for biotech companies emerging from hubs such as Biogen and Moderna.
The network maintains offices across major markets including New York City, London, Paris, Berlin, Toronto, Sydney, Singapore, Tokyo, Mumbai, São Paulo, and Johannesburg, coordinating regional operations with local agencies and international clients. It leverages partnerships with local creative shops and consultancies in markets influenced by policy from organizations such as the European Commission and trade agreements negotiated by entities like the World Trade Organization. Global hubs host multidisciplinary teams drawn from backgrounds at institutions including Oxford University, Imperial College London, and leading regional medical schools.
McCann Health and its campaigns have received recognition at industry shows and awards such as the Cannes Lions International Festival of Creativity, the Clio Awards, the Effie Awards, and the D&AD Awards, often competing alongside agencies from groups like WPP plc and Omnicom Group. The network's work has been cited in trade publications including Adweek, The Drum, and Campaign, and has been shortlisted for healthcare marketing honors from organizations such as the Healthcare Advertising Awards and the Medical Marketing & Media Awards.
Category:Advertising agencies Category:Health care companies